Key Trends and Insights into the VELETRI Market: Growth Rate and Opportunities to 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the market?
In recent times, the market size of VELETRI has seen robust growth. The expected market growth is from $1.34 billion in 2024 to $1.45 billion in 2025 with a compound annual growth rate (CAGR) of 7.9%. The past growth can be linked to various factors such as the escalating occurrence of pulmonary arterial hypertension (PAH), amplified awareness of PAH, a swelling geriatric populace, a worldwide rise due to shifts in lifestyle, and ballooning healthcare spending.
What will be the market size in the future?
Expectations are high for the VELETRI market to experience robust growth in the forthcoming years. The projections reveal a growth to $1.95 billion by 2029, with a CAGR of 7.7%. Factors contributing to this expansion during the forecast period include a higher incidence of venous diseases, increased awareness leading to early diagnosis, rising expenditure on chronic diseases, enhanced healthcare infrastructure, and an enlarging patient demographic. Technological progress, partnerships between pharma firms and research bodies, a solid clinical research pipeline, escalation in R&D operations, and the introduction of biosimilars and generics will be leading trends during the forecast period.
Get your market report here!
https://www.thebusinessresearchcompany.com/report/veletri-global-market-report
What are the major factors driving growth in the market?
The growing rate of pulmonary arterial hypertension (PAH), a rare and progressive condition marked by high blood pressure in the lung arteries, is set to fuel the expansion of the VELETRI market. Factors such as enhanced diagnostic techniques, an aging population, and heightened awareness are contributing to the increase in PAH cases. Veletri is employed to treat PAH and its effects, including improved exercise capacity and slowing down the disease’s progression through vasodilation. For instance, as per October 2022 data provided by the American College of Cardiology Foundation, a US-based non-profit medical society, PAH, being a rare condition, affects about 15 to 30 people per million. This increases in PAH cases contribute to the expansion of the VELETRI market. The VELETRI market will also likely see continued growth due to the rising incidence of venous diseases. These diseases impair venous blood flow, provoking complications like swelling, pain, varicose veins, and deep vein thrombosis. Factors like an aging population, sedentary lifestyles, obesity, and better diagnostic capabilities are driving the increase in venous disease cases. Veletri helps alleviate symptoms and enhance exercise capacity in patients with these illnesses that impact the pulmonary vasculature. For example, the Centers for Disease Control and Prevention highlighted in January 2025 that up to 900,000 individuals are affected by venous thromboembolism (VTE), a blood clot-related condition, annually in the United States, with an estimated death toll of 60,000 to 100,000 each year. Hence, the growing incidence of venous diseases boosts the VELETRI market’s growth.
What key areas define the segmentation of the global market?
The veletri market covered in this report is segmented –
1) By Product Type: Injectable, Inhalation
2) By Application: Pulmonary Arterial Hypertension, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Injectable: Intravenous (IV) Injection, Subcutaneous (SC) Injection
2) By Inhalation: Nebulized Inhalation, Dry Powder Inhalation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21314&type=smp
Who are the dominant players expanding their reach in the market?
Major companies operating in the veletri market are Johnson & Johnson, Bayer Pharma AG, Novartis AG, GlaxoSmithKline plc, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Actelion Pharmaceuticals Ltd., Euroapi S.A., United Therapeutics Corporation, Pfizer CentreOne, Sai Life Sciences Limited, Zhejiang Ausun Pharmaceutical Co. Ltd., Yonsung Fine Chemicals Co. Ltd., Cayman Pharma S.r.o., Meitheal Pharmaceuticals Inc., Smiths Medical, Guangzhou Tosun Pharmaceutical Co. Ltd.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21314
Which regions are emerging as leaders in the market?
North America was the largest region in the VELETRI market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veletri market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Complicated Skin And Skin Structure Infections Drugs Global Market Report 2025
Skin Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
Skin Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
